Advancing science, assessing long-term performance
As a national leader in implantable pain management systems, Nura physicians and researchers often work with medical device companies to study the long-term performance of specific devices.
Current Clinical Trials
Abbott: Spinal Cord Stimulator (SCS) and Dorsal Root Ganglion (DRG) Systems
- REALITY: Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator: NCT03876054
- PROLONG: Prospective, Multi-center, Open-label, Post-market Study: NCT03908476
- TARGET: A Post-Approval Study to Evaluate Targeted SCS (DRG) Stimulation for the management of Moderate to Severe Chronic, Intractable, Pain of the Lower Limbs due to CRPS Type I and II: NCT02800863
Medtronic: Targeted Drug Delivery Systems and Neurostimulator Systems
- Product Surveillance Registry (PSR) NCT01524276
You could be the one
Find out how you could help advance medicine. Call 952-937-9000 or send an email to research@nuraclinics.com to learn more about participating!